Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Luca Braglia, Manuela Zavatti, Marco Vinceti, Alberto M. Martelli, Sandra Marmiroli
Topics & Concepts
Prostate cancerPTENPI3K/AKT/mTOR pathwayMedicineAndrogen deprivation therapyCancerCancer researchProtein kinase BDruggabilityMalignancyProstateOncologyCabazitaxelInternal medicineBioinformaticsSignal transductionBiologyBiochemistryGenePI3K/AKT/mTOR signaling in cancerProstate Cancer Treatment and Research